Neurofeedback Therapy sessions last 60 minutes. Schedule Neurofeedback Therapy 2-3 times weekly for the number of sessions recommended by your physician and based on the purchased package. Schedule a baseline Brain Map or QEEG before starting Neurofeedback Therapy for customized protocol design and to evaluate concerns and observe benefit overtime.
The two most common types of dementia are Alzheimer’s disease and vascular dementia. The former caused by shrinkage of the brain due to a toxic build-up of Amyloid-beta and the latter is primarily caused by a history of strokes or mini-strokes resulting from ongoing vascular disease.
Neurofeedback therapy promotes optimal reorganization through principles of neuroplasticity. QEEG brain mapping provides areas of concern and helps certified Neurotherapist design specific and individualized neuro retraining programs for improving blood flow and nerve regeneration where it is needed most.
- Stimulates Blood Vessel Growth to Improve Blood Flow
- Improves Cerebral Oxygenation
- Enhances Memory and Mental Performance
- Reduces Brain Swelling
- Decreases Intracranial Pressure
- Increases Blood Flow to the Brain
- Reduces Blood-Brain Barrier Breakdown
- Minimizes Oxidative Stress
Increase Regeneration of the Nervous System
- Stimulates Brain Tissue Regeneration
- Promotes Proliferation and Mobilization of Neural Stem Cells
- Facilitates Neuroplasticity
Improve Brain Repair
- Recovers & Repairs Damaged Brain Tissue
- Develops & Regains Cognitive/Motor Function
Improve Overall Function
- Advances Cognitive Function
- Improves Gross/Fine Motor Skills
- Enhances Speech & Language
- Alleviates Spasticity
- Stimulates Better Eye Contact
- Improves Balance & Walking
- Reduces Anxiety
- Reduces Depression
- Improves quality of sleep
1.Irini Vilou et. al; EEG-Neurofeedback as a Potential Therapeutic Approach for Cognitive Deficits in Patients with Dementia, Multiple Sclerosis, Stroke and Traumatic Brain Injury. Life (Basel). 2023 Jan 29;13(2):365. doi: 10.3390/life13020365. PMID: 3683672. PMCID: PMC9966294
2.Lucas R Trambaiolli et al; Neurofeedback and the Aging Brain: A Systematic Review of Training Protocols for Dementia and Mild Cognitive Impairment. Front Aging Neurosci. 2021 Jun 9:13:682683. doi: 10.3389/fnagi.2021.682683. eCollection 2021.DOI:10.3389/fnagi. 2021.682683. PMID: 34177558. PMCID: PMC8221422
3.Yotam Lavy et al; Mild Cognitive Impairment and Neurofeedback: A Randomized Controlled Trial. Front Aging Neurosci. 2021; 13: 657646.Published online 2021 Jun 14. doi: 10.3389/fnagi. 2021.657646. PMID: 34194315. PMCID: PMC8236892
4.Robin E Luijme et. al; The effectiveness of neurofeedback on cognitive functioning in patients with Alzheimer’s disease: Preliminary results. Neurophysiol Clin. 2016 Jun;46(3):179-87. doi: 10.1016/j.neucli.2016.05.069. Epub 2016 Jun 30. PMID: 27374996
Research Supporting Neurofeedback for Cognitive Regeneration
Neurofeedback in healthy elderly human subjects with electroencephalographic risk for cognitive disorder.
J Alzheimers Dis. 2012;28(2):357-67. doi: 10.3233/JAD-2011-111055.
In normal elderly subjects, the best electroencephalogram (EEG)-based predictor of cognitive impairment is theta EEG activity abnormally high for their age. The goal of this work was to explore the effectiveness of a neurofeedback (NFB) protocol in reducing theta EEG activity in normal elderly subjects who present abnormally high theta absolute power (AP). Fourteen subjects were randomly assigned to either the experimental group or the control group; the experimental group received a reward (tone of 1000 Hz) when the theta AP was reduced, and the control group received a placebo treatment, a random administration of the same tone. The results show that the experimental group exhibits greater improvement in EEG and behavioral measures. However, subjects of the control group also show improved EEG values and in memory, which may be attributed to a placebo effect. However, the effect of the NFB treatment was clear in the EEG, although a placebo effect may also have been present.
EEG neurofeedback: a brief overview and an example of peak alpha frequency training for cognitive enhancement in the elderly.
Clin Neuropsychol. 2007 Jan;21(1):110-29
Neurofeedback (NF) is an electroencephalographic (EEG) biofeedback technique for training individuals to alter their brain activity via operant conditioning. Research has shown that NF helps reduce symptoms of several neurological and psychiatric disorders, with ongoing research currently investigating applications to other disorders and to the enhancement of non-disordered cognition. The present article briefly reviews the fundamentals and current status of NF therapy and research and illustrates the basic approach with an interim report on a pilot study aimed at developing a new NF protocol for improving cognitive function in the elderly. EEG peak alpha frequency (PAF) has been shown to correlate positively with cognitive performance and to correlate negatively with age after childhood. The present pilot study used a double-blind controlled design to investigate whether training older individuals to increase PAF would result in improved cognitive performance. The results suggested that PAF NF improved cognitive processing speed and executive function, but that it had no clear effect on memory. In sum, the results suggest that the PAF NF protocol is a promising technique for improving selected cognitive functions.